| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.26▼ | 1.26▼ | 1.26▼ | 1.28▼ | 1.24▼ |
| MA10 | 1.28▼ | 1.28▼ | 1.28▼ | 1.27▼ | 1.13▲ |
| MA20 | 1.29▼ | 1.28▼ | 1.28▼ | 1.26▼ | 0.85▲ |
| MA50 | 1.28▼ | 1.27▼ | 1.27▼ | 1.04▲ | 0.71▲ |
| MA100 | 1.27▼ | 1.26▼ | 1.25▼ | 0.82▲ | 1.39▼ |
| MA200 | 1.25▼ | 1.20▲ | 1.06▲ | 0.70▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.009▼ | -0.009▼ | -0.009▼ | -0.019▼ | N/A |
| RSI | 32.630▼ | 36.140▼ | 36.609▼ | 49.848▼ | N/A |
| STOCH | 12.500▼ | 9.444▼ | 9.444▼ | 50.113 | 69.803 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -89.744▼ | -31.792 |
| CCI | -206.158▼ | -219.033▼ | -219.033▼ | -148.737▼ | 57.851 |
|
Wednesday, June 24, 2020 06:32 AM
Enrollment is underway in a 195-subject Phase 2 clinical trial evaluating Aerpio Pharmaceuticals' (NASDAQ:ARPO) razuprotafib eye drop in patients with elevated intraocular pressure (IOP ...
|
|
Wednesday, June 24, 2020 05:00 AM
Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases, ARDS associated with COVID-19, and ...
|
|
Wednesday, June 24, 2020 01:00 AM
CINCINNATI, June 24, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 13/07/20 | 1.25 | 1.27 | 1.20 | 1.20 | 433,875 |
| 10/07/20 | 1.30 | 1.3299 | 1.25 | 1.26 | 398,078 |
| 09/07/20 | 1.31 | 1.375 | 1.26 | 1.32 | 873,410 |
| 08/07/20 | 1.29 | 1.32 | 1.28 | 1.31 | 271,424 |
| 07/07/20 | 1.26 | 1.33 | 1.255 | 1.29 | 355,387 |
| 06/07/20 | 1.27 | 1.34 | 1.26 | 1.28 | 1,564,178 |
| 02/07/20 | 1.27 | 1.2913 | 1.24 | 1.26 | 668,644 |
| 01/07/20 | 1.27 | 1.29 | 1.235 | 1.28 | 426,500 |
| 30/06/20 | 1.27 | 1.29 | 1.23 | 1.25 | 343,018 |
| 29/06/20 | 1.28 | 1.3283 | 1.21 | 1.26 | 802,925 |
|
|
||||
|
|
||||
|
|